W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

News

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑

Telefon

News

The Transparency Council meeting 7/2026 on 16 February 2026

Publication AWA

Status of work in February

Recommendation of the President – Braftovi (encorafenib)

Recommendation of the President – Mektovi (binimetinib)

Recommendation of the President – Calquence (acalabrutinib)

Recommendation of the President – Krazati (adagrabin)

The Transparency Council meeting 6/2026 on 9 February 2026

Status of work in February

Publication AWA

The Transparency Council meeting 5/2026 on 3 February 2026

/ The Transparency Council meeting 4/2026 on 2 February 2026

Publication AWA

Status of work in January

Recommendation of the President – Coatoris (ezetimibe + atorvastatin, 10 mg + 80 mg)

Recommendation of the President – Keytruda (pembrolizumab)

Recommendation of the President – Quviviq (daridoreksant)

Communication of the meeting of Transparency Council No. 2/2026 on 19 January 2026 with resolutions

Recommendation of the President – measurement of the ankle-brachial

Recommendation of the President – Lecigon (levodopa + carbidopa + entacapone)

Publication AWA

Status of work in January

Communication of the meeting of Transparency Council No. 1/2026 on 12 January 2026 with resolutions

The Transparency Council meeting 3/2026 on 26 January 2026

Page header

News

The Transparency Council meeting 7/2026 on 16 February 2026

Publication AWA

Status of work in February

Recommendation of the President – Braftovi (encorafenib)

Recommendation of the President – Mektovi (binimetinib)

Recommendation of the President – Calquence (acalabrutinib)

Recommendation of the President – Krazati (adagrabin)

The Transparency Council meeting 6/2026 on 9 February 2026

Status of work in February

Publication AWA

The Transparency Council meeting 5/2026 on 3 February 2026

/ The Transparency Council meeting 4/2026 on 2 February 2026

Publication AWA

Status of work in January

Recommendation of the President – Coatoris (ezetimibe + atorvastatin, 10 mg + 80 mg)

Recommendation of the President – Keytruda (pembrolizumab)

Recommendation of the President – Quviviq (daridoreksant)

Communication of the meeting of Transparency Council No. 2/2026 on 19 January 2026 with resolutions

Recommendation of the President – measurement of the ankle-brachial

Recommendation of the President – Lecigon (levodopa + carbidopa + entacapone)

Publication AWA

Status of work in January

Communication of the meeting of Transparency Council No. 1/2026 on 12 January 2026 with resolutions

The Transparency Council meeting 3/2026 on 26 January 2026